Researchers who participated in the WIN-R trial, the largest hepatitis C study ever conducted in U.S. patients, reported key factors affecting treatment outcomes in five data presentations here at the Digestive Disease Week (DDW) annual meeting, and provided important insights for optimizing treatment with PEG-INTRON® (peginterferon alfa-2b) and REBETOL® (ribavirin, USP) combination therapy for patients with chronic hepatitis C virus (HCV) infection, a potentially deadly liver disease. WIN-R (Weight-Based Dosing of PEG-INTRON and (REBETOL), a community-based trial, involved more than 4,900 patients at 225 centers across the United States.

Most children experience some degree of apprehension and excitement as the first day of school approaches, but what does it mean when a child is overcome with fear at the thought of separating from parents and caregivers to go to class?

Take extra care this Fourth of July and at all of your summer gatherings by ensuring that accidents do not interfere with warm weather fun.

In a novel approach to stroke research, investigators from NewYork-Presbyterian/Columbia University Medical Center and NewYork-Presbyterian/Weill Cornell Medical Center will collaborate to create the New York Stroke Trials Network of Columbia and Cornell. The network is one of 25 regional stroke centers across the country funded by the National Institutes of Health Stroke Trials Network (NIH StrokeNet), announced by the National Institutes of Health in December 2013.

Dr. Francis Lee, a psychiatrist and scientist at NewYork-Presbyterian Hospital/Weill Cornell Medical Center, has received a commendation by the president of the United States in the form of a Presidential Early Career Award for Scientists and Engineers (PECASE), the highest honor bestowed by the White House Office of Science and Technology Policy for outstanding scientists and engineers in the early part of their independent research careers.

Individuals diagnosed with a brain arteriovenous malformation (BAVM) — an abnormal tangle of arteries and veins — are at increased risk of vessel rupture and bleeding that can cause permanent brain damage. Traditionally, doctors have prescribed preventive interventions like surgery, but there is suggestive evidence that this invasive approach may actually increase risk of a rupture, at least in some patients.

A leading authority on preventive cardiology, Dr. Holly Andersen has been appointed director of education and outreach at the new Ronald O. Perelman Heart Institute of NewYork-Presbyterian Hospital/Weill Cornell Medical Center. The newly created position underscores the Institute's strong commitment to raising awareness about the risks of heart disease.

NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientists are presenting exciting new research at the 2009 American Transplant Congress in Boston from May 30 to June 3.